The healthcare-associated infectious disease diagnostics market is expected to grow at a CAGR of over 8% during the period 2018–2024

NEXT STORY
Opthea Presents Additional Data from OPT-302 Phase 2b Wet AMD Trial at the Ophthalmology Innovation Summit in San Francisco
PREV STORY
The global microbial identification panel market is expected to reach US$ 3,873.1 Mn in 2027 from US$ 2,288.7 Mn in 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apricus Biosciences Files NDA Resubmission for Vitaros™

SAN DIEGO, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News

New “Test and Treatment” Allergy Program Enables All Physicians To Provide Convenient And Effective Allergy Care

New York City, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Pediatric Allergy Solutions (“PAS”) and ...

author_avatar
NASDAQ Market News

ABLYNX ANNOUNCES WARRANT EXERCISE

REGULATED INFORMATION GHENT, Belgium, 15 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] ...

author_avatar
NASDAQ Market News